125 related articles for article (PubMed ID: 15635008)
1. Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.
Martinez-Picado J; Morales-Lopetegi K; Villena C; Gutiérrez C; Izquierdo N; Marfil S; Clotet B; Ruiz L
J Clin Microbiol; 2005 Jan; 43(1):436-8. PubMed ID: 15635008
[TBL] [Abstract][Full Text] [Related]
2. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
3. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
4. Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.
Izopet J; Souyris C; Hance A; Sandres-Sauné K; Alvarez M; Pasquier C; Clavel F; Puel J; Massip P
J Infect Dis; 2002 May; 185(10):1506-10. PubMed ID: 11992288
[TBL] [Abstract][Full Text] [Related]
5. Performance of the TruGene human immunodeficiency virus type 1 genotyping kit and OpenGene DNA sequencing system on clinical samples diluted to approximately 100 copies per milliliter.
Gale HB; Kan VL; Shinol RC
Clin Vaccine Immunol; 2006 Feb; 13(2):235-8. PubMed ID: 16467331
[TBL] [Abstract][Full Text] [Related]
6. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
7. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
[TBL] [Abstract][Full Text] [Related]
8. Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates.
Mo H; King MS; King K; Molla A; Brun S; Kempf DJ
J Virol; 2005 Mar; 79(6):3329-38. PubMed ID: 15731227
[TBL] [Abstract][Full Text] [Related]
9. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
J Clin Microbiol; 2001 Feb; 39(2):464-73. PubMed ID: 11158091
[TBL] [Abstract][Full Text] [Related]
10. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.
Wei X; Youngpairoj AS; Garrido C; Zahonero N; Corral A; de Mendoza C; Heneine W; Johnson JA; Garcia-Lerma JG
J Clin Virol; 2011 Feb; 50(2):148-52. PubMed ID: 21130027
[TBL] [Abstract][Full Text] [Related]
11. Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes.
Snoeck J; Riva C; Steegen K; Schrooten Y; Maes B; Vergne L; Van Laethem K; Peeters M; Vandamme AM
J Virol Methods; 2005 Sep; 128(1-2):47-53. PubMed ID: 15871907
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients.
Valer L; de Mendoza C; Soriano V
J Med Virol; 2005 Dec; 77(4):460-4. PubMed ID: 16254964
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
[TBL] [Abstract][Full Text] [Related]
15. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
Gonzalez LM; Santos AF; Abecasis AB; Van Laethem K; Soares EA; Deforche K; Tanuri A; Camacho R; Vandamme AM; Soares MA
J Antimicrob Chemother; 2008 Jun; 61(6):1201-4. PubMed ID: 18356151
[TBL] [Abstract][Full Text] [Related]
16. A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
Van Laethem K; Schrooten Y; Dedecker S; Van Heeswijck L; Deforche K; Van Wijngaerden E; Van Ranst M; Vandamme AM
J Virol Methods; 2006 Mar; 132(1-2):181-6. PubMed ID: 16271771
[TBL] [Abstract][Full Text] [Related]
17. In vitro synthesis of enzymatically active HIV-1 protease for rapid phenotypic resistance profiling.
Hoffmann D; Buchberger B; Nemetz C
J Clin Virol; 2005 Apr; 32(4):294-9. PubMed ID: 15780808
[TBL] [Abstract][Full Text] [Related]
18. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
[TBL] [Abstract][Full Text] [Related]
20. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
